SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 152 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $303,831 | -39.1% | 127,660 | +22.6% | 0.00% | – |
| Q2 2023 | $498,639 | -15.5% | 104,100 | 0.0% | 0.00% | – |
| Q1 2023 | $590,247 | +1.2% | 104,100 | 0.0% | 0.00% | – |
| Q4 2022 | $582,960 | -12.7% | 104,100 | 0.0% | 0.00% | – |
| Q3 2022 | $668,000 | +109.4% | 104,100 | +12.1% | 0.00% | – |
| Q2 2022 | $319,000 | -41.6% | 92,900 | +21.1% | 0.00% | – |
| Q1 2022 | $546,000 | -14.2% | 76,700 | +0.4% | 0.00% | – |
| Q4 2021 | $636,000 | -32.5% | 76,400 | -43.6% | 0.00% | – |
| Q3 2021 | $942,000 | -54.5% | 135,400 | +56.0% | 0.00% | -100.0% |
| Q2 2021 | $2,070,000 | +27.1% | 86,800 | +9.7% | 0.00% | 0.0% |
| Q1 2021 | $1,629,000 | -13.7% | 79,100 | +2.7% | 0.00% | 0.0% |
| Q4 2020 | $1,887,000 | +4.9% | 77,000 | +21.3% | 0.00% | 0.0% |
| Q3 2020 | $1,798,000 | +280.1% | 63,500 | -36.1% | 0.00% | – |
| Q2 2020 | $473,000 | +61.4% | 99,400 | +21.2% | 0.00% | – |
| Q1 2020 | $293,000 | +24.7% | 82,000 | +20.6% | 0.00% | – |
| Q4 2019 | $235,000 | -13.9% | 68,000 | 0.0% | 0.00% | – |
| Q3 2019 | $273,000 | +17.7% | 68,000 | -5.4% | 0.00% | – |
| Q2 2019 | $232,000 | -29.3% | 71,900 | +50.7% | 0.00% | – |
| Q1 2019 | $328,000 | +63.2% | 47,700 | +7.4% | 0.00% | – |
| Q4 2018 | $201,000 | -40.9% | 44,400 | -0.9% | 0.00% | – |
| Q3 2018 | $340,000 | -8.8% | 44,800 | +3.2% | 0.00% | – |
| Q2 2018 | $373,000 | +22.7% | 43,400 | +4.8% | 0.00% | – |
| Q1 2018 | $304,000 | -24.9% | 41,400 | +3.8% | 0.00% | – |
| Q4 2017 | $405,000 | -39.3% | 39,900 | -4.1% | 0.00% | – |
| Q3 2017 | $667,000 | +41.9% | 41,600 | 0.0% | 0.00% | – |
| Q2 2017 | $470,000 | +28.1% | 41,600 | +27.6% | 0.00% | – |
| Q1 2017 | $367,000 | +7.6% | 32,600 | -5.2% | 0.00% | – |
| Q4 2016 | $341,000 | -19.4% | 34,400 | 0.0% | 0.00% | – |
| Q3 2016 | $423,000 | -96.5% | 34,400 | -91.7% | 0.00% | -100.0% |
| Q2 2016 | $12,106,000 | +6.3% | 416,740 | -2.8% | 0.01% | 0.0% |
| Q1 2016 | $11,384,000 | -14.2% | 428,608 | +13.3% | 0.01% | -9.1% |
| Q4 2015 | $13,269,000 | – | 378,136 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $93,092,000 | 26.99% |
| ARK Investment Management | 2,406,723 | $17,665,000 | 0.88% |
| Virtus ETF Advisers LLC | 76,713 | $563,000 | 0.49% |
| Bison Wealth, LLC | 33,929 | $249,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,525 | $143,000 | 0.10% |
| Rock Springs Capital Management LP | 220,000 | $1,615,000 | 0.07% |
| FEDERATED HERMES, INC. | 1,766,681 | $12,968,000 | 0.04% |
| Spark Investment Management LLC | 79,500 | $583,000 | 0.04% |
| A.R.T. Advisors, LLC | 45,952 | $337,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 88,684 | $651,000 | 0.01% |